SMC recommends restricted use of Dasatinib/Sprycel

Dasatinib (Sprycel) is accepted for restricted use for the treatment of adults with chronic myeloid leukaemia (CML) with resistance or intolerance to prior therapy including imatinib mesylate ...more

scottishmedicines.org.uk/smc/smc_display.jsp?pContentID=5309&p_applic=CCC&p_service=Content.show&">...more